Canadian specialty pharmaceutical company

Specialty medicines and rare disease access in Türkiye.

From oncology and haematology to cystic fibrosis, blood products and rare diseases, Pharmet brings specialty therapies to patients in Türkiye through the Foreign Drug List, with the reliability and continuity that complex treatments demand.

Capsules and tablets in soft natural light
  • 2Countries of operation
    Canada & Türkiye
  • 10Specialty
    therapeutic areas
  • 4Step access
    pathway
  • TrustedPartnerships with
    public institutions
A physician speaking with a patient and family member

About Pharmet

A Canadian specialty company, active in Türkiye.

Pharmet Pharmaceutical is a Canadian specialty pharmaceutical company with operations in Canada and Türkiye. We have specialty products added to Türkiye's Foreign Drug List and supply them to clinicians and patients on a patient-by-patient basis, helping them reach therapies that are not yet licensed locally.

Our expertise spans oncology, haematology, cystic fibrosis and other rare diseases. Strong, cooperative relationships with public institutions support smooth access coordination and continuity of treatment.

  • Specialist therapeutic expertise
  • Established local operations
  • Institutional supply coordination

Products

Therapeutic areas we work in.

Ten specialty therapeutic areas, from rare genetic disease to advanced cell therapy and plasma-derived medicines.

Cystic fibrosis

Specialty treatments for paediatric and adult patients.

Gene-related diseases

Therapies for rare genetic and metabolic conditions.

Oncology

Specialty medicines for solid tumours and haemato-oncology.

Autoimmune diseases

Specialty medicines for immune-mediated conditions.

Hormone-related diseases

Endocrine and hormonal therapies.

CAR-T cell therapy

Advanced, cell-based therapies for complex conditions.

Neurology

Specialty medicines for neurological conditions.

Women's health

Medicines for gynaecological and women's health conditions.

Haematology

Treatments for blood disorders.

Blood products

Plasma-derived therapies for immune, bleeding and critical-care needs.

  • IVIG
  • Human albumin
  • Coagulation factors

Availability of each therapeutic area depends on its regulatory status and the applicable access route in Türkiye.

Supply of Pharmaceuticals from Abroad · Named Patient Program

Access to specialty medicines, ahead of local licensing.

Internationally known as Supply of Pharmaceuticals from Abroad or the Named Patient Program (NPP), this pathway allows specialty products that are not yet licensed in Türkiye to be added to the Active Foreign Drug List, the List of Foreign Drugs Supplied by the Turkish Pharmacists' Association (TEB), so they can be supplied patient by patient before Turkish marketing authorisation. Product documentation and institutional arrangements are prepared in parallel, so supply can begin as soon as the prerequisites are met.

Two routes to the Foreign Drug List

A

Turkish Pharmacists' Association (TEB)

Products are added to the Active Foreign Drug List maintained by the Turkish Pharmacists' Association (TEB) and supplied patient by patient.

B

Social Security Institution

Where applicable, products are supplied through the Social Security Institution.

  1. 01

    Product assessment

    We review international authorisation, Turkish regulatory status, clinical evidence and the permitted source of supply.

  2. 02

    Access preparation

    We prepare the product documentation and support the listing application, whether through the Turkish Pharmacists' Association (TEB) or the Social Security Institution.

  3. 03

    Funding & procurement

    Applicable payer conditions and purchase terms are resolved through the authorised channel.

  4. 04

    Supply & follow-up

    Eligible patient orders are fulfilled with full traceability, supported by safety reporting and timely replenishment.

Subject to eligibility, required TİTCK permissions, applicable funding conditions and supply readiness.

Institutional relationships

Strong, cooperative relationships with public institutions.

We operate actively within the Foreign Drug List channel, built on constructive working relationships with public institutions. Every product is supported by clinical and economic dossiers and by procurement offers covering price, lead time and continuity.

Funding remains subject to product and patient conditions.

Medical engagement

Science-led and fully within scope.

We provide medical information, disease education and safety communication within the scope permitted for each product.

Medical and promotional activities follow each product's regulatory status. Clinical decisions always remain independent.

Supply & quality

Dependable supply of specialty medicines.

  • ForecastingRolling forecasts and early escalation of potential shortages.
  • Quality & traceabilityControlled transport conditions, batch-level traceability and structured complaint handling.
  • PharmacovigilanceClearly defined pharmacovigilance responsibilities and recall coordination.
Pharmaceutical vials and packaging on a laboratory bench

Our teams

The specialists behind every delivery.

01

Medical & specialty medicines

Scientific information and specialist engagement within the permitted scope.

02

Market access & institutional accounts

Payer preparation and coordination of authorised procurement.

03

Regulatory, quality & pharmacovigilance

Product documentation, quality agreements and safety obligations.

04

Supply & finance

Forecasting, order execution, payment terms and receivables.

Contact

Let's talk about access to specialty medicines.

Questions about our therapeutic areas, the access pathway or our work in Türkiye? Reach out and our team will get back to you.

OfficePharmet Pharmaceutical Inc.1110 Finch Ave West
North York, ON, Canada